Literature DB >> 19087128

A study for maternal thyroid hormone deficiency during the first half of pregnancy in China.

Z Y Shan1, Y Y Chen, W P Teng, X H Yu, C Y Li, W W Zhou, B Gao, J R Zhou, B Ding, Y Ma, Y Wu, Q Liu, H Xu, W Liu, J Li, W W Wang, Y B Li, C L Fan, H Wang, R Guo, H M Zhang.   

Abstract

BACKGROUND: Maternal thyroid hormone deficiency is the most common disorder of thyroid function during pregnancy and can influence the outcome for mother and foetus. The purpose of this study was to investigate the prevalence of thyroid hormone deficiency during the first half of pregnancy in iodine sufficient areas of China.
MATERIALS AND METHODS: Four thousand eight hundred pregnant women from 10 hospitals during the first 20 weeks of gestation were enrolled in this study. All sera obtained from pregnant women were measured for thyrotropin, free thyroxine and thyroid peroxidase antibody. Screening for thyroid hormone deficiency was performed on pregnant women using gestational age-specific reference intervals or non-pregnant population reference intervals.
RESULTS: With gestational age-specific reference intervals as the criterion, the prevalence of subclinical hypothyroidism at 4, 8, 12,16 and 20 weeks of gestation was 4.59%, 6.15%, 4.68%, 4.53% and 5.96%, respectively, and the prevalence of hypothyroxinaemia was 3.69%, 1.11%, 2.92%, 1.29% and 2.29%, respectively. Different prevalence was obtained when non-pregnant population reference intervals was used as the criterion. If non-pregnant population reference intervals were used, the percentage of potentially misclassified cases of subclinical hypothyroidism were 0.18%, 2.85%, 4.1%, 3.24%, and 3.21%, respectively, and 3.45%, 0.66%, 2.34%, 1.29%, and 1.83%, respectively, in potentially misclassified cases of hypothyroxinaemia.
CONCLUSIONS: The percentage of potentially misclassified cases of subclinical hypothyroidism and hypothyroxinaemia in pregnant women decreased by using the gestational age-specific reference intervals as a diagnostic criteria during the first half of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19087128     DOI: 10.1111/j.1365-2362.2008.02055.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  24 in total

Review 1.  Thyroid hormone therapy of hypothyroidism in pregnancy.

Authors:  Zhongyan Shan; Weiping Teng
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

Review 2.  Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia.

Authors:  R M Furnica; J H Lazarus; D Gruson; C Daumerie
Journal:  J Endocrinol Invest       Date:  2014-11-05       Impact factor: 4.256

Review 3.  Reporting Thyroid Function Tests in Pregnancy.

Authors:  Alan R McNeil; Phoebe E Stanford
Journal:  Clin Biochem Rev       Date:  2015-11

Review 4.  Subclinical hypothyroidism and related biochemical entities in pregnancy: implications and management.

Authors:  D S A McLeod; H D McIntyre
Journal:  Obstet Med       Date:  2010-12-03

5.  Population Reference Values and Prevalence Rates following Universal Screening for Subclinical Hypothyroidism during Pregnancy of an Afro-Caribbean Cohort.

Authors:  Nadine Johnson; Vikash Chatrani; Anna-Kay Taylor-Christmas; Eric Choo-Kang; Monica Smikle; Rosemarie Wright-Pascoe; Karen Phillips; Marvin Reid
Journal:  Eur Thyroid J       Date:  2014-10-10

6.  Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy.

Authors:  S Wang; W P Teng; J X Li; W W Wang; Z Y Shan
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

7.  Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study.

Authors:  Haixia Liu; Zhongyan Shan; Chenyan Li; Jinyuan Mao; Xiaochen Xie; Weiwei Wang; Chenling Fan; Hong Wang; Hongmei Zhang; Cheng Han; Xinyi Wang; Xin Liu; Yuxin Fan; Suqing Bao; Weiping Teng
Journal:  Thyroid       Date:  2014-09-17       Impact factor: 6.568

8.  The pattern of thyroid function of subclinical hypothyroid women with levothyroxine treatment during pregnancy.

Authors:  Xiaohui Yu; Yanyan Chen; Zhongyan Shan; Weiping Teng; Chenyang Li; Weiwei Zhou; Bo Gao; Tao Shang; Jiaren Zhou; Bin Ding; Ying Ma; Ying Wu; Qun Liu; Hui Xu; Wei Liu; Jia Li; Weiwei Wang; Yuanbin Li; Chenling Fan; Hong Wang; Hongmei Zhang; Rui Guo
Journal:  Endocrine       Date:  2013-03-19       Impact factor: 3.633

9.  Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus.

Authors:  Hao Ying; Yu-Ping Tang; Yi-Rong Bao; Xiu-Juan Su; XueYa Cai; Yu-Hong Li; De-Fen Wang
Journal:  Endocrine       Date:  2016-07-16       Impact factor: 3.633

10.  Maternal Subclinical Hypothyroidism Impairs Neurodevelopment in Rat Offspring by Inhibiting the CREB Signaling Pathway.

Authors:  Yuanyuan Zhang; Yuxin Fan; Xiaohui Yu; Xinyi Wang; Suqing Bao; Jiashu Li; Chenling Fan; Zhongyan Shan; Weiping Teng
Journal:  Mol Neurobiol       Date:  2014-09-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.